Conference Coverage

Primary Care Rivals Specialists on Apnea Management

View on the News

Good for Most Patients

There’s been a growing interest in primary care OSA management to save money and increase access to care, not just in Australia, but also in the United States and elsewhere, said Mary Morrell, Ph.D.

It hasn’t been clear, however, "whether all patients with sleep apnea need to be seen in a [sleep center] and have complicated studies, or whether you can [treat them] in primary care settings." The study demonstrates "you can, and it’s a lot cheaper. It works well for the majority of people," Dr. Morrell said.

Dr. Morrell is a professor of sleep and respiratory physiology at the Imperial College London. She reported having no relevant financial disclosures.


 

FROM THE INTERNATIONAL CONFERENCE OF THE AMERICAN THORACIC SOCIETY

SAN FRANCISCO – Outpatient sleep apnea management by primary care physicians and nurses works as well as management by specialists in a sleep center and is less expensive, Australian researchers reported at the International Conference of the American Thoracic Society.

The team randomized 155 patients with symptomatic, moderate to severe obstructive sleep apnea (OSA) – all with baseline Epworth Sleepiness Scale (ESS) scores of at least 8 – to either standard management by sleep specialists with sleep-lab testing or outpatient management by their primary care doctor and a community-based nurse. Primary care management often involved home-based, autotitrating CPAP (continuous positive airway pressure), but providers in both arms were free to prescribe whatever treatment they thought best.

Obstructive sleep apnea had first been diagnosed by the primary care doctors using screening and ESS questionnaires, plus home oximetry testing with the ApneaLink device, manufactured by ResMed. They and the nurses had six hours of OSA training before the trial, plus training about common sleep disorders and their differential diagnoses. Nurses had an additional week of training at a sleep center.

After 6 months, patients managed by the primary care group had a mean ESS improvement of 4.9 points and a mean Functional Outcomes of Sleep Questionnaire (FOSQ) improvement of 2.3 points. The mean ESS improvement in the specialist group was 5.1, and the mean FOSQ improvement was 2.7. The differences were not statistically significant.

CPAP machines were being used a mean of 4.8 hours per day at 6 months in the primary care group and a mean of 5.4 hours per day in the specialist group. Again, the difference was not significant.

Outpatient OSA management saved more than $2,000 (AUS) per patient, as well.

"Our results show that using a simplified, ambulatory approach for the treatment of OSA in primary care is not clinically inferior to management of these patients in a specialist sleep center," said lead investigator Dr. Ching Li Chai-Coetzer of the Adelaide Institute for Sleep Health at the Repatriation General Hospital in Adelaide, Australia.

"We think in rural, remote areas and in the developing world, as obesity emerges and sleep apnea becomes more of a clinical issue, the traditional models of care are not going to be available to all patients. We think these results may have some important implications in these areas," said Dr. Nicholas Antic, also an investigator from the Adelaide Institute for Sleep Health.

Dr. Chai-Coetzer and Dr. Antic said they had no relevant financial conflicts. The equipment used in the study was donated by ResMed, Philips Respironics, and SomnoMed.

Recommended Reading

Rotigotine Patch Has Favorable Results in Parkinson's, Restless Legs
MDedge Internal Medicine
Hypertonic Not Better Than Isotonic Saline in Young Cystic Fibrosis Patients
MDedge Internal Medicine
Asthma Prevalence Up 15% Since 2001
MDedge Internal Medicine
Shorter Treatment Failed for Ventilator-Assisted Pneumonia
MDedge Internal Medicine
CPFE Syndrome Seen in Smokers Without Connective Tissue Disease
MDedge Internal Medicine
Hodgkin's Survivors Face High Breast Cancer Risk
MDedge Internal Medicine
Delamanid Boosts Treatment Punch in Resistant TB
MDedge Internal Medicine
Roughly 14 Million Americans Have Undiagnosed COPD
MDedge Internal Medicine
Pregabalin Tested Better for RLS Than Did Pramipexole
MDedge Internal Medicine
9/11 Survivors 50% More Likely to Have Respiratory Symptoms
MDedge Internal Medicine